MedTrace Logo

Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans

NCT01317290 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2013-11-13

No results posted yet for this study

Summary

The objective of this study is to investigate the accumulation of n-3 LC-PUFA (EPA, DPA and DHA) in human lipids by oral supplementation of ALA-rich linseed oil. In addition, the accumulation of n-3 LC-PUFA is compared between subpopulations of different age, gender and physiological conditions (overweight, increased serum total cholesterol).

Conditions

Interventions

DIETARY_SUPPLEMENT

n-3 PUFA free olive oil

negative control

DIETARY_SUPPLEMENT

linseed oil

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • University of Jena

    lead OTHER

Principal Investigators

  • Katrin Kuhnt, Dr. rer. nat · University of Jena, Insitute of Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-09-30
Completion
2013-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01317290 on ClinicalTrials.gov